ImmuCell Corp. (ICCC)
5.85
-0.26
(-4.26%)
USD |
NASDAQ |
Feb 03, 16:00
5.85
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Market Cap : 52.92M for Feb. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Becton, Dickinson & Co. | 58.94B |
| Cumberland Pharmaceuticals, Inc. | 57.13M |
| AbbVie, Inc. | 398.77B |
| Precipio, Inc. | 40.30M |
| NovaBay Pharmaceuticals, Inc. | 145.73M |
Market Cap Related Metrics
| PE Ratio | 22.60 |
| PS Ratio | 1.896 |
| Price to Book Value | 1.776 |
| Price to Free Cash Flow | 73.59 |
| Price | 5.85 |
| Earnings Yield | 4.43% |
| Operating PE Ratio | 22.60 |
| Normalized PE Ratio | 22.60 |